With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.
Apple hit that milestone in August, and then Amazon did in early September. The winner is Amazon. According to CNBC calculations, a $1,000 investment in Amazon in September 2008 would be worth more than $23,890 as of Friday morning, or more than 22 times as much, including price appreciation and dividends reinvested.
If Ford (NYSE:F) stock was a car, it would be…an Edsel. There’s something else: Ford must deal with the technological disruptions in the auto industry. Keep in mind that the company’s CEO, James Hackett, has been making bold moves.
It was a name that we found early, allowing us to nab IQ stock in the low-$20s. Anyway, maybe investors are now wondering whether iQiyi stock is a buy at current levels. After its huge rise, IQ stock has come back to earth and has been basing in the $26 to $28 range.
Traders Josh Brown, Jim Lebenthal, Stephanie Link and Jon Najarian are joined by Mario Gabelli, chairman and CEO of Gamco Investors, to discuss the record rally in the markets.
Canopy Rivers, the venture-capital arm of Canopy Growth, made its debut on the Toronto Stock Exchange Thursday morning at $18.44 per share. The company, which makes minority investments in burgeoning marijuana companies, in an attempt to become the "Google Ventures of cannabis," found its way onto the exchange via a reverse takeover with a company formerly known as AIM2 Ventures.
General Electric Company (NYSE: GE) confirmed this week that it has had a major failure in one of its turbines at the Colorado Bend power plant. J.P. Morgan analyst Stephen Tusa says it's unclear just how big of a deal the failure is at this point. Regardless, Tusa says GE can't afford more blows to its battered reputation, and the failure will negatively impact its power segment business in the near term.
SECTORFOCUS BLOG AT&T rose on Friday, helped by an upgrade from (UBS). Where we were: AT&T has lagged this year, like other telecom stocks, although company-specific worries also weighed on the shares. Where we’re headed: UBS
XIAN/BEIJING (Reuters) - At least two cargoes of U.S. soybeans are heading for China as some buyers are willing to risk taking up historically cheap U.S. beans even amid worries that Beijing may take further steps to deter imports amid mounting trade tensions with Washington. Grain traffic from the United States to China has nearly ground to a halt since Beijing hit $50 billion in U.S. imports, including soybeans, with hefty tariffs, in retaliation for a similar move by Washington. The buyers of the beans, which are used to make meal for animal feed and oil for cooking, are not known, and the cargoes may have been booked before the tariffs were introduced.
RESEARCH REPORTS These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of
The 11 pointers I recently gave to investors to carefully make money in marijuana stocks have generated a lot of interest. In some ways, Denver-based New Age Beverages is the new Tilray. Tilray has been the most explosive marijuana stock.
Investors will be hoping for strength from BABA as it approaches its next earnings release, which is expected to be November 1, 2018. In that report, analysts expect BABA to post earnings of $1.25 per share. It is also important to note the recent changes to analyst estimates for BABA.
Instead, I think there is one pot stock out there that is worth buying and holding amid the cannabis craze. CGC stock is different than its peers. Canopy also spends a fair amount on R&D, and has a venture arm that is further diversifying investor exposure to the cannabis market.
Warren Buffett’s conglomerate has ended the summer as a red-hot stock. While there hasn’t been any major news to account for the recent advance in Berkshire shares, it’s clear that investors like the more flexible policy on stock buybacks. Berkshire has bought “a little” stock under the new authorization, Buffett told CNBC on Aug. 30—his 88th birthday— but he didn’t provide any more specifics.
It has truly been an impressive run for Microsoft (NASDAQ:MSFT). Microsoft stock has almost quadrupled in the past six years, with the price of MSFT stock rising from under $30 to its current level around $114. Now that the price of Microsoft stock has cleared those levels – and then some – some of my original skepticism has returned.
Investors are still looking with a cautious eye toward next week’s Fed meeting, but with Q3 earnings season on the horizon, it is possible a thaw in the trade war could give way to further gains. The memory chip giant beat earnings estimates and posted decent profit guidance, but investors were not impressed. With that said, investors can always prepare for these events with the Zacks Earnings Calendar.
Snap (NYSE:SNAP), the parent company of messaging platform Snapchat, was following in the footsteps of highly successful social networking companies like Facebook (NASDAQ:FB) and Twitter (NYSE:TWTR). After launching its IPO at a price of $17 in March of last year and trading as high as $29.44 just a few days later, SNAP stock has dwindled to a mere $9.12 right now. It’s a reality faithful fans, followers and owners of SNAP stock are largely going to reject.
As wages grow and inflation remains tame, this could give the retail sector the boost investors have been waiting for. Names like Target (NYSE:TGT), TJX Companies (NYSE:TJX), Home Depot (NYSE:HD) and others have helped to push the SPDR Retail ETF (NYSEARCA:XRT) higher. As for the ETF, it’s move above $51 resistance was important, as this level has become a key level of support going into the all-important second half.
Naturally, Warren Buffett’s and his lieutenant stock picks are often at the top of most investors must see list. While it’s not Buffett’s first foray with owning Goldman, it is his biggest outright purchase of GS stock. The truth is, Goldman Sachs could be quickly becoming a great Buffett pick.
Move over bitcoin and ilk: Shares of Canadian marijuana companies went through the roof this week after the U.S. Drug Enforcement Administration approved Tilray’s plan to import a medical cannabis product. The ETFMG Alternative Harvest ETF (MJ) — which holds many Canadian marijuana stocks — was up 22% for one week through Thursday.
MU fell as much as 4.9% in Friday's trading and had been down some 7% in after-hours trading Thursday evening after the firm guided the current quarter's earnings to $2.88 to $3.02 per share vs. the $3.08 that analysts had been expecting. The drop in the share price comes as analysts are almost universally tempering their own earnings estimates for the company. Seventeen of the 18 analysts who published research on the company so far in September have cut their price targets, according to FactSet data.
Investors shouldn’t let pot stock Tilray Inc.’s (TLRY) wild trading week turn them off from the marijuana sector, rival cannabis concern Canopy Growth Corp. (CGC) CEO Bruce Linton said on CNBC Friday. The fledgling sector is much more stable than Tilray’s headlines would imply, Linton insists, after Nasdaq had to halt Tilray trading five times during Wednesday’s session. This means Tilray is not the sector proxy that Wall Street makes it out to be, Linton argued.
Pfizer, Inc. PFE announced that it has received Breakthrough Therapy designation for its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, from the FDA. The designation was granted on the basis of positive immunogenicity data from a phase II study of the multivalent pneumococcal conjugate vaccine in adults aged 60 to 64 years. Pfizer’s stock has outperformed the industry this year so far.
could be a good buying opportunity Friday as its shares slide on concerns over tariff troubles and weakened forward guidance. "We remain overweight MU and would accumulate shares on weakness," J.P. Morgan analyst Harlan Sur wrote Friday, indicating his belief that positive future trends in semiconductors, coupled with the company's big share-buyback program, should reward longer-term investors. While Sur joined a parade of analysts trimming their price expectations for the stock, he maintained a "Buy" rating on MU and a $75 price target.